Common stock, shares authorized (in shares)

[Index to Consolidated Financial Statements](#ibab9fb71d67648f0b758869f160b7f4b_100)  
Consolidated Balance Sheets

|  |  |  |  |  |  |  |  |  |  |  |  |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
|  |  |  |  |  |  |  |  |  |  |  |  |
|  | At December 31, |
| In millions, except per share amounts | 2021 |  | 2020 |
| Assets: |  |  |   |
| Cash and cash equivalents | $ | 9,408  |  |  | $ | 7,854  |  |
| Investments | 3,117  |  |  | 3,000  |  |
| Accounts receivable, net | 24,431  |  |  | 21,742  |  |
| Inventories | 17,760  |  |  | 18,496  |  |
| Other current assets | 5,292  |  |  | 5,277  |  |
| Total current assets | 60,008  |  |  | 56,369  |  |
| Long-term investments | 23,025  |  |  | 20,812  |  |
| Property and equipment, net | 12,896  |  |  | 12,606  |  |
| Operating lease right-of-use assets | 19,122  |  |  | 20,729  |  |
| Goodwill | 79,121  |  |  | 79,552  |  |
| Intangible assets, net | 29,026  |  |  | 31,142  |  |
| Separate accounts assets | 5,087  |  |  | 4,881  |  |
| Other assets | 4,714  |  |  | 4,624  |  |
| Total assets | $ | 232,999  |  |  | $ | 230,715  |  |
|  |  |  |  |
| Liabilities: |  |  |  |
| Accounts payable | $ | 12,544  |  |  | $ | 11,138  |  |
| Pharmacy claims and discounts payable | 17,330  |  |  | 15,795  |  |
| Health care costs payable  | 8,808  |  |  | 7,936  |  |
| Policyholders’ funds | 4,301  |  |  | 4,270  |  |
| Accrued expenses | 17,670  |  |  | 14,243  |  |
| Other insurance liabilities | 1,303  |  |  | 1,557  |  |
| Current portion of operating lease liabilities | 1,646  |  |  | 1,638  |  |
|  |  |  |  |
| Current portion of long-term debt | 4,205  |  |  | 5,440  |  |
| Total current liabilities | 67,807  |  |  | 62,017  |  |
| Long-term operating lease liabilities | 18,177  |  |  | 18,757  |  |
| Long-term debt | 51,971  |  |  | 59,207  |  |
| Deferred income taxes | 6,270  |  |  | 6,794  |  |
| Separate accounts liabilities | 5,087  |  |  | 4,881  |  |
| Other long-term insurance liabilities | 6,402  |  |  | 7,007  |  |
| Other long-term liabilities | 1,904  |  |  | 2,351  |  |
| Total liabilities | 157,618  |  |  | 161,014  |  |
| Commitments and contingencies (Note 16) |  |  |  |
|  |  |  |  |
| Shareholders’ equity: |  |  |  |
| Preferred stock, par value $0.01: 0.1 shares authorized; none issued or outstanding | —  |  |  | —  |  |
| Common stock, par value $0.01: 3,200 shares authorized; 1,744 shares issued and 1,322 shares outstanding at December 31, 2021 and 1,733 shares issued and 1,310 shares outstanding at December 31, 2020 and capital surplus | 47,377  |  |  | 46,513  |  |
| Treasury stock, at cost: 422 and 423 shares at December 31, 2021 and 2020 | (28,173) |  |  | (28,178) |  |
| Retained earnings | 54,906  |  |  | 49,640  |  |
| Accumulated other comprehensive income | 965  |  |  | 1,414  |  |
| Total CVS Health shareholders’ equity | 75,075  |  |  | 69,389  |  |
| Noncontrolling interests | 306  |  |  | 312  |  |
| Total shareholders’ equity | 75,381  |  |  | 69,701  |  |
| Total liabilities and shareholders’ equity | $ | 232,999  |  |  | $ | 230,715  |  |

  
See accompanying notes to consolidated financial statements.105
